Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents

被引:0
|
作者
Jean-Marc Barret
Anna Kruczynski
Chantal Etiévant
Bridget T. Hill
机构
[1] Division de Cancérologie,
[2] Centre de Recherche Pierre Fabre,undefined
[3] 17 avenue Jean Moulin,undefined
[4] 81100 Castres,undefined
[5] France,undefined
来源
关键词
F 11782 Combination index Synergy Cultured cells In vivo;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:479 / 486
页数:7
相关论文
共 50 条
  • [41] Topostatin, a novel inhibitor of topoisomerases I and II produced by Thermomonospora alba strain no 1520 -: I.: Taxonomy, fermentation, isolation and biological activities
    Suzuki, K
    Nagao, K
    Monnai, Y
    Yagi, A
    Uyeda, M
    JOURNAL OF ANTIBIOTICS, 1998, 51 (11): : 991 - 998
  • [42] Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds
    Fujiki, Hirota
    Sueoka, Eisaburo
    Watanabe, Tatsuro
    Suganuma, Masami
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (09) : 1511 - 1522
  • [43] Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds
    Hirota Fujiki
    Eisaburo Sueoka
    Tatsuro Watanabe
    Masami Suganuma
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 1511 - 1522
  • [44] Topostatin, a novel inhibitor of topoisomerases I and II produced by Thermomonospora alba strain no. 1520 -: III.: Inhibitory properties
    Suzuki, K
    Yamaizumi, M
    Tateishi, S
    Monnai, Y
    Uyeda, M
    JOURNAL OF ANTIBIOTICS, 1999, 52 (05): : 460 - 465
  • [45] The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action
    Lee, Margaret S.
    Johansen, Lisa
    Zhang, Yanzhen
    Wilson, Amy
    Keegan, Mitchell
    Avery, William
    Elliott, Peter
    Borisy, Alexis A.
    Keith, Curtis T.
    CANCER RESEARCH, 2007, 67 (23) : 11359 - 11367
  • [46] QSAR Study on Hetaryl Imidazoles: A Novel Dual Inhibitor of VEGF Receptors I and II
    Patel, Asha
    Karthikeyan, C.
    Moorthy, N. S. H. N.
    Trivedi, P.
    MEDICINAL CHEMISTRY, 2010, 6 (01) : 24 - 29
  • [47] A Synergistic Anticancer FAK and HDAC Inhibitor Combination Discovered by a Novel Chemical-Genetic High-Content Phenotypic Screen
    Dawson, John C.
    Serrels, Bryan
    Byron, Adam
    Muir, Morwenna T.
    Makda, Ashraff
    Garcia-Munoz, Amaya
    von Kriegsheim, Alex
    Lietha, Daniel
    Carragher, Neil O.
    Frame, Margaret C.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (02) : 637 - 649
  • [48] Novel Gold(I) Thiolate Derivatives Synergistic with 5-Fluorouracil as Potential Selective Anticancer Agents in Colon Cancer
    Atrian-Blasco, Elena
    Gascon, Sonia
    Jesus Rodriguez-Yoldi, Ma
    Laguna, Mariano
    Cerrada, Elena
    INORGANIC CHEMISTRY, 2017, 56 (14) : 8562 - 8579
  • [49] Topostatin, a novel inhibitor of topoisomerases I and II produced by Thermomonospora alba strain no 1520 -: II.: Physico-chemical properties and structure elucidation
    Suzuki, K
    Yahara, S
    Kido, Y
    Nagao, K
    Hatano, Y
    Uyeda, M
    JOURNAL OF ANTIBIOTICS, 1998, 51 (11): : 999 - 1003
  • [50] Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex
    Zhang, W
    Perry, KW
    Wong, DT
    Potts, BD
    Bao, JQ
    Tollefson, GD
    Bymaster, FP
    NEUROPSYCHOPHARMACOLOGY, 2000, 23 (03) : 250 - 262